Advertisement
Research Article

The Case for Selection at CCR5-Δ32

  • Pardis C Sabeti mail,

    To whom correspondence should be addressed. E-mail: pardis@broad.mit.edu

    Affiliations: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Emily Walsh,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Steve F Schaffner,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Patrick Varilly,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Ben Fry,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Holli B Hutcheson,

    Affiliation: Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Mike Cullen,

    Affiliation: Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Tarjei S Mikkelsen,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Jessica Roy,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Nick Patterson,

    Affiliation: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America

    X
  • Richard Cooper,

    Affiliation: Department of Preventive Medicine and Epidemiology, Loyola University Medical School, Maywood, Illinois, United States of America

    X
  • David Reich,

    Affiliations: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • David Altshuler,

    Affiliations: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Molecular Biology and Center for Human Genetic Research, Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America

    X
  • Stephen O'Brien,

    Affiliation: Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Eric S Lander

    Affiliations: Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Published: November 01, 2005
  • DOI: 10.1371/journal.pbio.0030378

Reader Comments (2)

Post a new comment on this article

typo

Posted by plosbiology on 07 May 2009 at 22:11 GMT

Author: Malcolm Campbell
Position: faculty
Institution: Davidson College
E-mail: macampbell@davidson.edu
Submitted Date: November 01, 2005
Published Date: November 4, 2005
This comment was originally posted as a “Reader Response” on the publication date indicated above. All Reader Responses are now available as comments.

In "The Case for Selection at CCR5-¿32", the words can not should be cannot.

No competing interests declared.